CRA International CRA Delivers Record Quarter Continuing Growth Trajectory RTO Q4 2025 Earnings EPS Misses Estimates as Profit Falls Short of Consensus Innovent Biologics Surges 10 on Potential 105 Billion Oncology Deal with Pfizer